Orion Nutraceuticals Announces Management Changes
(TheNewswire)
Vancouver, British Columbia – May8, 2025 – TheNewswire - Orion NutraceuticalsInc. , (CSE: ORI ) (the “ Company ” or“ Orion ”) announces theappointment of Troy Grant as a Director of the Company.
Mr. Grant brings a wealth of experience in corporateleadership, capital markets, and strategic growth across a range ofindustries. His appointment supports Orion’s ongoing commitment tostrengthening its governance and advancing its strategicobjectives.
The Company welcomes Mr. Grant to the Board and looksforward to benefiting from his insight and contributions.
About Orion NutraceuticalsInc.
Orion Nutraceuticals Inc. is actively evaluating potential investmentand acquisition opportunities. Orion shares trade in Canada on the CSEunder the symbol ORI.
ON BEHALF OF THE BOARD
Guy Bourgeois, CEO
Tel: ( 604) 687-2038
The CSE andInformation Service Provider have not reviewed and does not acceptresponsibility for the accuracy or adequacy of this release.
This news release may containforward-looking statements based on assumptions and judgments ofmanagement regarding future events or results. Such statements aresubject to a variety of risks and uncertainties which could causeactual events or results to differ materially from those reflected inthe forward-looking statements. The company disclaims any intention orobligation to revise or update such statements. For a description ofthe risks and uncertainties facing the Company and its business andaffairs, readers should refer to the Company’s Management’sDiscussion and Analysis and other disclosure filings with Canadiansecurities regulators, which are posted on www.sedarplus.ca.
Copyright (c) 2025 TheNewswire - All rights reserved.
NASDAQ: ORONF
ORONF Trading
0.0% G/L:
$0.2862 Last:
400 Volume:
$0.2862 Open:



